Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Candidate retinal vascular metrics in patients with newly diagnosed cancer: a prospective pilot cohort study
Author Affiliations & Notes
  • Andrew F Smith
    MedMetrics Inc., Ontario, Canada
    Department of Ophthalmology, King's College London, London, United Kingdom
  • Vishaal Bhambhwani
    Department of Ophthalmology, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada
    Department of Ophthalmology, NOSM University, Thunder Bay, Ontario, Canada
  • Grégoire Le Gal
    Department of Hematology, University of Ottawa, Ottawa, Ontario, Canada
    School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada
  • Leland Dhurjon
    Department of Ophthalmology, Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada
  • Emanuele Trucco
    Computing, School of Science and Engineering, University of Dundee, Dundee, Scotland, United Kingdom
  • Stephen Hogg
    Computing, School of Science and Engineering, University of Dundee, Dundee, Scotland, United Kingdom
  • Tom MacGillivray
    The University of Edinburgh Division of Health Sciences, Edinburgh, Edinburgh, United Kingdom
  • Adam Threlfall
    The University of Edinburgh Division of Health Sciences, Edinburgh, Edinburgh, United Kingdom
  • Footnotes
    Commercial Relationships   Andrew Smith MedMetrics Inc., Code C (Consultant/Contractor), Alcon, Code C (Consultant/Contractor); Vishaal Bhambhwani Northern Ontario Academic Medicine Association, Code F (Financial Support), Orbis Canada, Code R (Recipient), Bayer Inc., Code R (Recipient); Grégoire Le Gal None; Leland Dhurjon None; Emanuele Trucco None; Stephen Hogg None; Tom MacGillivray None; Adam Threlfall Optos, Code F (Financial Support)
  • Footnotes
    Support  Northern Ontario Academic Medicine Association (NOAMA) Clinical Innovation Opportunities Fund Award
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6017. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Andrew F Smith, Vishaal Bhambhwani, Grégoire Le Gal, Leland Dhurjon, Emanuele Trucco, Stephen Hogg, Tom MacGillivray, Adam Threlfall; Candidate retinal vascular metrics in patients with newly diagnosed cancer: a prospective pilot cohort study. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6017.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate the difference between retinal vascular measurements in a cohort of newly diagnosed cancer patients and matched cancer-free controls.

Methods : Participants newly diagnosed with cancer were recruited through the Cancer Centre of the Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada. Age and sex matched cancer-free controls were recruited from the wider hospital community. All participants had digital retinal images taken using an OPTOS ultra-widefield scanning laser ophthalmoscope in an outpatient ambulatory eye clinic setting. Retinal images were analyzed using the VAMPIRE (Vascular Assessment and Measurement Platform for Images of the REtina) software application which characterises the retinal vasculature. Differences in the numeric values between retinal vascular measurements in the cancer and cancer-free cohorts were assessed using Analysis of Variance (ANOVA) and effect sizes calculated using the ETA-squared statistic with a P-Value of <0.05 deemed to be statistically significant.

Results : A total of 160 participants were recruited, including 59 controls and 101 cases for which readable digital retinal images were available for analysis. The mean age of controls and cases was 57.5 and 62.2 years of age, respectively (P <0.038) and 57 % of all participants were female. The main types of newly diagnosed cancer included: breast (n=31); hematological/leukemia (n=21); prostate (n=11); thyroid (n=10); lung (n=7); all others (n=21), respectively. Approximately 17% (40/234) of all VAMPIRE retinal measurements were found to be significantly different between cases and controls. A small to medium effect size for differences in fractal dimension values for retinal vascular measures in the peripheral retinal arteries; vessels and veins was observed with ETA-squared values of 0.012-0.014; 0.012-0.018 and 0.021-0.029, respectively.

Conclusions : Retinal vascular metrics, specifically fractal dimension values in the peripheral retina displayed a small to medium effect size between persons with and without cancer. Further research is required to explore the capture of retinal images and refinements in the use of appropriate retinal vascular metrics as a possible adjunct tool for further stratifying persons at an elevated risk for developing cancer, thereby potentially improving early detection and overall cancer survival.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×